AmacaThera animation showcases company’s unique biotechnology

   Press Release

In June 2022, we created and published Meet AmacaThera and learn about our novel hydrogel platform,” a one-minute animation that outlines its approach to drug development.

Watch our platform animation below.

AmacaThera’s goal is to revolutionize the range of treatment options available to patients in multiple areas using multiple therapeutic agents, such as small molecules, antibodies, proteins or peptides.

The company’s hydrogel platform could be used to deliver long-lasting treatments with a variety of therapeutic applications, including post-surgical pain management, cancer, and other targeted areas that require therapeutic care, such as the brain.

About AmacaThera

AmacaThera is a clinical-stage biotechnology company developing a novel drug delivery platform to improve patient outcomes across multiple therapeutic areas, including post‑surgical pain management, cancer and other hard‑to‑reach target areas.

Learn more about our technology.

More Recent News

How AMT-143 could reduce the post-surgical need for opioids

   Press Release

In June 2022, we created and published “Meet AmacaThera and learn about our novel hydrogel platform,” a 35-second animation. Watch the animated explainer inside this article.Read more

AmacaThera featured in Innovate Toronto

   Media Coverage

AmacaThera’s drug development platform is featured in Innovate Toronto, an in-depth look at Toronto’s innovation ecosystem. The online compendium and coffee table book features over 300 start-up success stories, including Kepler, which aims to take the Internet into space, and Altus Assessments, which is using data and tech to bring the human side of healthcare education back into focus.
Read more

AmacaThera CEO Mike Cooke accepted to adMare BioInnovations 2021-22 Executive Institute

   Press Release

adMare BioInnovations is pleased to announce the nine women and nine men from diverse backgrounds and representing a wide range of life science businesses across the country, selected to join this year’s adMare Academy Executive Institute.Read more

Amacathera Logo

AmacaThera is a clinical-stage biotechnology company transforming therapeutics to make a difference in patient health. Our unique, injectable hydrogel platform provides localized, sustained drug delivery to improve patient outcomes across multiple therapeutic areas, including post‑surgical pain management, cancer and other hard‑to‑reach target areas.

Contact Us

661 University Ave, Suite 1300
Toronto, ON M5G 0B7, Canada

info@amacathera.ca